MIG Capital LLC Buys Shares of 149,163 Humana Inc. (NYSE:HUM)

MIG Capital LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 149,163 shares of the insurance provider’s stock, valued at approximately $37,844,000. Humana makes up about 3.9% of MIG Capital LLC’s investment portfolio, making the stock its 13th largest position. MIG Capital LLC owned 0.12% of Humana at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HUM. Transcend Capital Advisors LLC raised its holdings in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after buying an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC raised its stake in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after acquiring an additional 26,856 shares during the last quarter. Retirement Systems of Alabama lifted its position in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after acquiring an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Humana by 7.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after purchasing an additional 65,735 shares during the last quarter. Finally, Secure Asset Management LLC acquired a new position in shares of Humana in the fourth quarter valued at about $244,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $253.37 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $30.58 billion, a PE ratio of 25.46, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a fifty day moving average of $267.58 and a two-hundred day moving average of $271.85.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of recent research reports. Morgan Stanley dropped their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Truist Financial upped their price objective on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. JPMorgan Chase & Co. reduced their target price on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. StockNews.com lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 18th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Eighteen analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $280.17.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.